Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
20.68
+0.08 (0.39%)
At close: Apr 2, 2026, 4:00 PM EDT
20.78
+0.10 (0.48%)
After-hours: Apr 2, 2026, 7:48 PM EDT
Definium Therapeutics Market Cap
Definium Therapeutics has a market cap or net worth of $2.06 billion as of April 2, 2026. Its market cap has increased by 308.29% in one year.
Market Cap
2.06B
Enterprise Value
1.69B
1-Year Change
308.29%
Ranking
Category
Stock Price
$20.68
Market Cap Chart
Since March 4, 2020, Definium Therapeutics's market cap has increased from $595.37M to $2.06B, an increase of 246.30%. That is a compound annual growth rate of 22.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 2.06B | 56.31% |
| Dec 31, 2025 | 1.32B | 158.44% |
| Dec 31, 2024 | 510.39M | 247.80% |
| Dec 29, 2023 | 146.75M | 77.54% |
| Dec 30, 2022 | 82.66M | -85.99% |
| Dec 31, 2021 | 590.17M | -82.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nektar Therapeutics | 2.21B |
| Ultragenyx Pharmaceutical | 2.20B |
| ADMA Biologics | 2.19B |
| Tyra Biosciences | 2.13B |
| Aurinia Pharmaceuticals | 2.08B |
| Celldex Therapeutics | 2.07B |
| Agios Pharmaceuticals | 2.06B |
| Soleno Therapeutics | 2.04B |